Considering that an aging population is increasing due to a low birth rate in most developed nations, the maintenance of healthy state and physical and social activities is needed to maintain the national productivities. Among the diseases which deprive elderly people of activities and impose medical and care expenditure, cardiovascular diseases such as stroke, ischemic heart disease, heart failure and renal failure take major parts. These cardiovascular diseases occur based on the development and progression of arteriosclerotic vascular lesions, namely, vascular aging. Because hypertension is a major risk factor for vascular aging, the adequate control of blood pressure is pivotally important in order to prevent the incidence of cardiovascular events in the later stage of life. This is also concerned with the socio-economical issues and national productivity. Vol. 17, No. 3, September 2011 ISSN 2233-8136 http://dx.doi.org/10.5646/jksh.2011 Copyright ⓒ 2011. The Korean Society of Hypertension
riosclerosis, however, other lifestyle-related diseases such as diabetes mellitus and dyslipidemia synergistically promote the arteriosclerotic process.
When considering the risk of vascular aging, the idea of metabolic syndrome (Met-S) has been recognized widely. Namely, elevations in blood pressure and/or blood glucose below the diagnosis criteria for hypertension and diabetes mellitus when accompanied by waist circumference expansion and dyslipidemia offer a significant increase in the risk of cardiovascular diseases. 1, 2) In Met-S, the waist circumference increase is brought about by the deposition of visceral fat especially in men.
The visceral fat produces mediators such as angiotensinogen, transforming growth factor-alpha, registin and free fatty acids which facilitate the development of hypertension, diabetes mellitus and dyslipidemia. On the other hand, the production of adiponectin, which has protective clinical settings including hypertension. [11] [12] [13] In addition to the classical risk factors for arteriosclerosis, such as hypertension and dyslipidemia, oxidative stress has been attracting considerable attention as one of the novel risk factors for cardiovascular injury.
Oxidative stress depletes nitric oxide and cause endothelial dysfunction that initiates arteriosclerosis. Oxidized low-density lipoprotein (LDL) generated by oxidative stress also promotes the progression of arteriosclerosis. [14] [15] [16] As described earlier, enhancement of the RAA system is supposed to increase oxidative stress and elicit inflammation in the cardiovascular tissues. Namely, angiotensin II increases oxidative stress by activating nicotinamide adenine dinucleotide-phosphate (NAD[P]H) oxidase, and induce proinflammatory transcription factor NF-kB. 17, 18) Thus, it is surmised that various cardiovascular risk factors elicit these biochemical and immunological reactions which bring about cardiovascular tissue lesions and injuries including vascular aging.
Evaluation of vascular aging
The process of arteriosclerosis is initiated by the occur- Pulse wave velocity (PWV) is an indicator of arterial stiffness and an increased PWV has been shown to reflect a higher risk of cardiovascular disease. 19, 20) However, it has been pointed out that the PWV varies according to the changes of blood pressure and sympathetic activity.
7,21)
The cardio-ankle vascular index (CAVI) is calculated by adjusting PWV for blood pressure based on a stiffness parameter (β) and is thought to be a more accurate index of arterial stiffness.
22,23)
Chronic kidney disease and vascular aging
It has been now recognized that the existence of CKD imposes a great risk not only for the progression of renal failure but also for the development of cardiovascular diseases and thereby worsens the life prognosis. 24) Considering that the kidney is rich in vessels including glomeruli, it seems natural to assume that the vascular aging develops in the cardiovascular system including brain, heart and peripheral arteries in parallel with the renal vasculature. Therefore, in the treatment of CKD patients, the strict control of blood pressure is primarily needed in order to prevent deterioration of renal function and progression of cardiovascular organ injuries based on the vascular aging. 25) However, hypertension in CKD tends to be resistant to therapy because the renal dysfunction is involved in the etiology, 26) and multiple anti- (Fig. 6) . 40) Thus, also in CKD patients, the combination antihypertensive drug therapy with RASI and CCB is supposed to offer protective effects against vascular aging and deterioration of renal function.
Summary and conclusion
In order to prevent cardiovascular diseases and car- 
